Arlo Technologies Insider Sold Shares Worth $334,325, According to a Recent SEC Filing-March 2024-www.financetom.com

Arlo Technologies Insider Sold Shares Worth $334,325, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Arlo Technologies Insider Sold Shares Worth $334,325, According to a Recent SEC Filing

Jun 17, 2024 10:14 AM

12:46 PM EDT, 06/17/2024 (MT Newswires) -- Amy M Rothstein, Director, on June 13, 2024, sold 25,000 shares in Arlo Technologies ( ARLO ) for $334,325. Following the Form 4 filing with the SEC, Rothstein has control over a total of 76,271 shares of the company, with 76,271 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1736946/000141588924017076/xslF345X03/form4-06172024_040615.xml

Price: 12.89, Change: +0.07, Percent Change: +0.55

Previous page： Volatus Aerospace Acquires Strategic Dual-Use UAS Technology to Support Canada’s Sovereign Capability and Allied Defense Requirements Worldwide Next page： Cytokinetics Insider Sold Shares Worth $256,725, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Volatus Aerospace Acquires Strategic Dual-Use UAS Technology to Support Canada’s Sovereign Capability and Allied Defense Requirements Worldwide

Oct 27, 2025

Acquisition includes advanced suite of highly modular dual-use defense assets with near-term commercialization potentialSynergistic with the Company’s new Mirabel Innovation and Manufacturing Centre announced October 21, 2025This adds a line of multiple mass producible strategic UAS to Volatus’s in-house product portfolio MIRABEL, Quebec, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Volatus Aerospace Inc. ( TAKOF ) (“Volatus” or the “Company”), a...

Cytokinetics Insider Sold Shares Worth $256,725, According to a Recent SEC Filing

Oct 27, 2025

06:00 PM EDT, 10/27/2025 (MT Newswires) -- Wendell Wierenga, Director, on October 27, 2025, sold 4,375 shares in Cytokinetics ( CYTK ) for $256,725. Following the Form 4 filing with the SEC, Wierenga has control over a total of 32,444 common shares of the company, with 32,444 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1061983/000106198325000026/xslF345X05/form4.xml ...

VSE Agrees to Acquire Aero 3 for $350 Million

Oct 27, 2025

05:59 PM EDT, 10/27/2025 (MT Newswires) -- VSE (VSEC) said Monday it agreed to acquire Aero 3, a global maintenance, repair, and overhaul service provider and distributor, for $350 million in cash, subject to adjustments. The company said the deal expands VSE Aviation's presence in the commercial wheel and brake aftermarket, adding nine repair facilities across the US, Canada, and...

Agilent Technologies Appoints Adam Elinoff as CFO

Oct 27, 2025

05:59 PM EDT, 10/27/2025 (MT Newswires) -- Agilent Technologies ( A ) appointed Adam Elinoff as chief financial officer, effective Nov. 17. Elinoff, 48, was most recently treasurer at Amgen ( AMGN ) , Agilent ( A ) said Monday in a regulatory filing. He replaces Rodney Gonsalves, who served as interim CFO since July 31. Gonsalves will continue to...